new BindingDB logo
myBDB logout

BDBM144753 US8952128, 12::US8952128, 46

SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1

InChI Key: InChIKey=JIIISTFEPCPGJL-LFWACCAQNA-N

Data: 8 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 144753   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0600 -13.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.520 -12.7n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.740 -12.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
3.20 -11.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
31.6n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
98.9 -9.55n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
143 -9.33n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
255n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair